The transformation of CD4+ TCM cells into CD8+ TRM cells in PAAD tissue appears to be a favorable occurrence, suggesting potential benefits in future PAAD immunotherapy by harnessing the specific anti-tumor effects of these TM. Here, CD8A is linked to neoplasm.